Cargando…

Evaluation of a New ‘Mix-In’ Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia

(1) Background: Poor palatability, large volume, and lack of variety of some liquid and powdered protein substitutes (PSs) for patients with phenylketonuria (PKU) and tyrosinemia (TYR) can result in poor adherence. This study aimed to evaluate a new unflavoured, powdered GMP-based PS designed to be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delsoglio, Marta, Capener, Rebecca, MacDonald, Anita, Daly, Anne, Ashmore, Catherine, Donald, Sarah, Gaff, Lisa, VanDorp, Louise, Skeath, Rachel, Ellerton, Charlotte, Newby, Camille, Dunning, Georgina, Dale, Clare, Hunjan, Inderdip, White, Lucy, Allen, Heather, Hubbard, Gary P., Stratton, Rebecca J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459832/ https://www.ncbi.nlm.nih.gov/pubmed/37630788 http://dx.doi.org/10.3390/nu15163598

Ejemplares similares

Evaluation of a New Glycomacropeptide-Based Protein Substitute in Powdered and Liquid Format in Patients with PKU
por: Delsoglio, Marta, et al.
Publicado: (2023)

Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I
por: Daly, Anne, et al.
Publicado: (2021)

The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria
por: Daly, Anne, et al.
Publicado: (2020)

The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis
por: Pena, Maria João, et al.
Publicado: (2018)

The Use of Glycomacropeptide in Dietary Management of Phenylketonuria
por: Zaki, Osama K., et al.
Publicado: (2016)

Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria
por: Daly, Anne, et al.
Publicado: (2020)

Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective
por: Pena, Maria João, et al.
Publicado: (2021)

Protein Degradation and the Pathologic Basis of Phenylketonuria and Hereditary Tyrosinemia
por: Sarodaya, Neha, et al.
Publicado: (2020)

Dietary management of maternal phenylketonuria with glycomacropeptide and amino acids supplements: A case report
por: Pinto, A., et al.
Publicado: (2017)

Nutritional and Metabolic Characteristics of UK Adult Phenylketonuria Patients with Varying Dietary Adherence
por: Green, Benjamin, et al.
Publicado: (2019)

Biomarkers of Micronutrients in Regular Follow-Up for Tyrosinemia Type 1 and Phenylketonuria Patients
por: van Vliet, Kimber, et al.
Publicado: (2019)

Low Bone Strength Is a Manifestation of Phenylketonuria in Mice and Is Attenuated by a Glycomacropeptide Diet
por: Solverson, Patrick, et al.
Publicado: (2012)

Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial(1)(2)
por: Ney, Denise M, et al.
Publicado: (2016)

Glycomacropeptide Safety and Its Effect on Gut Microbiota in Patients with Phenylketonuria: A Pilot Study
por: Montanari, Chiara, et al.
Publicado: (2022)

Glycomacropeptide in PKU—Does It Live Up to Its Potential?
por: Daly, Anne, et al.
Publicado: (2022)

The influence of parental food preference and neophobia on children with phenylketonuria (PKU)
por: Evans, Sharon, et al.
Publicado: (2017)

Accidental Consumption of Aspartame in Phenylketonuria: Patient Experiences
por: Newbould, Ella, et al.
Publicado: (2021)

Phenylalanine free infant formula in the dietary management of phenylketonuria
por: Yilmaz, Ozlem, et al.
Publicado: (2023)

Transitioning of protein substitutes in patients with phenylketonuria: evaluation of current practice
por: Yilmaz, Ozlem, et al.
Publicado: (2022)

Parent’s Perception of the Types of Support Given to Families with an Infant with Phenylketonuria
por: Cassidy, Sophie, et al.
Publicado: (2023)

The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model
por: Ahring, Kirsten K., et al.
Publicado: (2022)

An Observational Study Evaluating the Introduction of a Prolonged-Release Protein Substitute to the Dietary Management of Children with Phenylketonuria
por: MacDonald, Anita, et al.
Publicado: (2020)

Growth and Body Composition in PKU Children—A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes
por: Daly, Anne, et al.
Publicado: (2021)

Uniformity of Food Protein Interpretation Amongst Dietitians for Patients with Phenylketonuria (PKU): 2020 UK National Consensus Statements
por: Evans, Sharon, et al.
Publicado: (2020)

Neurocognitive outcome and mental health in children with tyrosinemia type 1 and phenylketonuria: A comparison between two genetic disorders affecting the same metabolic pathway
por: van Vliet, Kimber, et al.
Publicado: (2022)

Hepatorenal tyrosinemia
por: KITAGAWA, Teruo
Publicado: (2012)

Special Low Protein Foods Prescribed in England for PKU Patients: An Analysis of Prescribing Patterns and Cost
por: Wood, Georgina, et al.
Publicado: (2021)

Metabolomic Insights into the Nutritional Status of Adults and Adolescents with Phenylketonuria Consuming a Low-Phenylalanine Diet in Combination with Amino Acid and Glycomacropeptide Medical Foods
por: Stroup, Bridget M., et al.
Publicado: (2017)

Unveiling the Metabolic Effects of Glycomacropeptide
por: Pena, Maria João, et al.
Publicado: (2021)

Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU
por: Daly, A., et al.
Publicado: (2019)

Dietetic Management of Adults with Phenylketonuria (PKU) in the UK: A Care Consensus Document
por: Robertson, Louise, et al.
Publicado: (2022)

A 3 Year Longitudinal Prospective Review Examining the Dietary Profile and Contribution Made by Special Low Protein Foods to Energy and Macronutrient Intake in Children with Phenylketonuria
por: Daly, Anne, et al.
Publicado: (2020)

Impact on Diet Quality and Burden of Care in Sapropterin Dihydrochloride Use in Children with Phenylketonuria: A 6 Month Follow-Up Report
por: Gama, Maria Inês, et al.
Publicado: (2023)

Impact of Fruit and Vegetable Protein vs. Milk Protein on Metabolic Control of Children with Phenylketonuria: A Randomized Crossover Controlled Trial
por: Pinto, Alex, et al.
Publicado: (2022)

Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls
por: van Ginkel, Willem G., et al.
Publicado: (2016)

Dietary Management, Clinical Status and Outcome of Patients with Citrin Deficiency in the UK
por: Pinto, Alex, et al.
Publicado: (2020)

Preliminary Data on Free Use of Fruits and Vegetables Containing Phenylalanine 76–100 mg/100 g of Food in 16 Children with Phenylketonuria: 6 Months Follow-Up
por: Pinto, Alex, et al.
Publicado: (2023)

The Effect of Various Doses of Phenylalanine Supplementation on Blood Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients
por: van Ginkel, Willem G., et al.
Publicado: (2019)

Syndrome of hereditary tyrosinemia in mink
por: Christensen, K, et al.
Publicado: (1978)

Dietary amino acid intakes associated with a low-phenylalanine diet combined with amino acid medical foods and glycomacropeptide medical foods and neuropsychological outcomes in subjects with phenylketonuria
por: Stroup, Bridget M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4cvn32ksrgnoe5lhmi7i6desvu